STAAR Surgical (STAA) Misses Q4 EPS by 66c
Tweet
Share
E-mailGet Alerts STAA Hot Sheet
Price: $24.09 --0%
Financial Fact:
Research and development: 4.45M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Research and development: 4.45M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
STAAR Surgical (NASDAQ: STAA) reported Q4 EPS of ($0.69), $0.66 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $48.95 million versus the consensus estimate of $77.2 million.
For earnings history and earnings-related data on STAAR Surgical (STAA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evogene (EVGN) Tops Q2 EPS by 15c
- Tango Therapeutics Inc. (TNGX) PT Raised to $68 at H.C. Wainwright
- H.C. Wainwright Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
